BRIEF-Rovi Sees Operating Revenue To Increase By Mid-To High-Single-Digit Percentage Vs 2025

3

Nov 5 (Reuters) – Laboratorios Farmaceuticos Rovi, S.A. : * 9-MONTH NET PROFIT €162.8 MILLION * 9-MONTH OPERATING REVENUE €610.2 MILLION * UPGRADES ITS 2026 OPERATING REVENUE GUIDANCE * NOW EXPECTS

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)